Developing automated and interactive methods for building a mechanistic and potentially causal model of ranked biomarkers followed by incorporation into a contextual framework in disease-linked biochemical pathways can be used for potential drug-target evaluation and for proposing new drug targets. This is part of the illuminating the druggable genome (IDG) project.